AIA
ASND icon

Angeles Investment Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Angeles Investment Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,250
Closed -$709K – 118
2020
Q4 		$709K Buy
+4,250
New +$703K 0.07% 56

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Angeles Investment Advisors's ASND Position: Q1 2021 in Review

Angeles Investment Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2021, closing a stake of 4,250 shares — an estimated $709K sold.

Angeles Investment Advisors first reported a position in ASND in Q4 2020 and held it in 1 quarter. The position peaked at $709K in Q4 2020. 177 funds tracked by Wall St. Rank hold ASND as of Q1 2021.

  • Angeles Investment Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2021 after selling out during the quarter.
  • Angeles Investment Advisors sold 4,250 Ascendis Pharma A/S shares in Q1 2021, an estimated $709K.
  • Angeles Investment Advisors first reported a position in Ascendis Pharma A/S in Q4 2020 and held it in 1 quarter.
  • Angeles Investment Advisors's Ascendis Pharma A/S position peaked at $709K in Q4 2020.
  • 177 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2021.

Based on Angeles Investment Advisors's 13F filing for Q1 2021, filed 17 May 2021.